# ADVAIR HFA

NDC: 0173-0716
Generic name: fluticasone propionate and salmeterol xinafoate
Labeler / Manufacturer: GlaxoSmithKline LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: AEROSOL, METERED
Routes: RESPIRATORY (INHALATION)
Marketing started: 20080929

FDA application: NDA021254

## Active ingredients

- FLUTICASONE PROPIONATE: 115 ug/1
- SALMETEROL XINAFOATE: 21 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0173-0716"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0173-0716

